Carolyn B. Levy
Pfizer (United States)(US)
Publications by Year
Research Areas
Carbohydrate Chemistry and Synthesis, Glycogen Storage Diseases and Myoclonus, Biochemical and Molecular Research, Cardiac Ischemia and Reperfusion, Microbial Natural Products and Biosynthesis
Most-Cited Works
- → Anilinoquinazoline Inhibitors of Fructose 1,6-Bisphosphatase Bind at a Novel Allosteric Site: Synthesis, In Vitro Characterization, and X-ray Crystallography(2002)82 cited
- → Effects of skyrin, a receptor-selective glucagon antagonist, in rat and human hepatocytes.(2000)64 cited
- → Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.(1998)58 cited
- → Cardioprotective effects of ingliforib, a novel glycogen phosphorylase inhibitor(2004)57 cited
- → 5-Chloroindoloyl glycine amide inhibitors of glycogen phosphorylase: synthesis, in vitro, in vivo, and X-ray crystallographic characterization(2004)28 cited
- → The Sulfonylurea Glipizide Does Not Inhibit Ischemic Preconditioning in Anesthetized Rabbits(2005)25 cited
- → Endogenous effectors of human liver glycogen phosphorylase modulate effects of indole-site inhibitors(2005)17 cited